Global 3D Cell culture Market - Growth, Trends and Forecast 2017 - 2022 - Product Image

Global 3D Cell culture Market - Growth, Trends and Forecast 2017 - 2022

  • ID: 4388596
  • Report
  • Region: Global
  • 211 pages
  • Mordor Intelligence
1 of 3
The global 3D Cell culture market was valued at an estimated $XX million in 2013 and is poised to grow at a CAGR of XX% from 2013 to 2018, to reach $XX million by 2018. The market is expected to reach USD XX million by 2021, growing at a CAGR of XX% during the forecast period of 2016 to 2021.

Cell culture is a process by which prokaryotic cells or eukaryotic cells are artificially grown outside their natural environment in a laboratory under controlled conditions. 3D cell culture is accepted as a new dimension of cell culture sector in biomedical research field. Research laboratories and institutes, hospitals, and biopharmaceutical and biotechnology companies are adopting 3D cell culture for better outputs and the adoption rate is posed to increase rapidly in the near future.

The Huge investment by Life science companies for R&D, Development of automated large-scale cell culture systems, Rise in Research and Development Investments, Rising need for organ transplantation, Use of 3D Cell Culture models as an alternative tool for in vivo testing and increasing focus on regenerative medicine are key factors propelling the growth of the market. However, Lack of experienced and skilled professionals, Budget restriction for small and medium sized laboratories, Lack of consistency in 3D cell culture products and stringent process controls for advanced handling capabilities are turning out to be restraints for the market.

The 3D Cell culture market is segmented on the basis of Technology, Applications and the End user. The Technology segment is further categorized into Extracellular matrices (Scaffolds), Bioreactors, Gels, Scaffold-free platforms, Microchips and others. The Applications segment includes Research, Drug discovery, Tissue engineering, Clinical applications, Stem cell biology and others. By End user, the 3D Cell culture market is segmented into Research laboratories and institutes, Biotechnology and pharmaceutical industries, Hospitals and diagnostic centers and others.

This report have been geographically segmented into North America, Europe, Asia-Pacific, Middle East & Africa and South America. The North American region have been further segmented into USA, Canada and Mexico. The Europe region have been sub-divided into Germany, France, UK, Spain, Italy, Scandinavia, Benelux and Rest of Europe. The Asia-Pacific market have been segmented into Japan, China, India, South Korea, Australia & New Zealand and Rest of Asia-Pacific. The Middle East & African market have been subdivided into GCC countries, South Africa and rest of Middle East and Africa. The South American market have been segmented into Brazil, Argentina and rest of South America.

Europe dominates the 3D cell culture market. The U.K. represents the largest market for 3D cell culture in the region. This is due to rising investment in 3D cell culture market, increasing research related activities, and 3D cell culture’s ability to replace the animal in research and pharmaceutical testing. The APAC region presents an array of opportunities for growth and is likely to be getting attention of new investors in the 3D cell culture market. Asia-pacific region is expected to grow at the highest CAGR due to increased healthcare awareness, improved economic growth, low operating cost and increased outsourcing. Significant new product launches, mergers and acquisitions, collaborations, joint ventures are some of the industry trends that are playing a major role for the market growth.

The key players in the market are 3D Biomatrix, Inc (U.S.), 3D Biotek LLC (U.S.), Becton, Dickinson and Company (U.S.), Corning Incorporated (U.S.), Thermo Fisher Scientific (U.S.), Global Cell Solutions Inc, (U.S.), InSphero AG (Switzerland), Lonza Group (Switzerland), Nano 3D Biosciences (U.S.), Nanofiber Solutions Incorporation (U.S.), Sigma Aldrich Corporation (U.S.) and Reinnervate Ltd, (A subsidiary of ReproCELL) (U.K.). and others.

Key Deliverables:

Market analysis for the Global 3D Cell culture market, with region specific assessments and competition analysis.

Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on regional scale

Extensively researched competitive landscape section with profiles of major companies along with their market shares

Identification and analysis of the macro and micro factors that affect the Global 3D Cell culture market

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market

Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
READ MORE
Note: Product cover images may vary from those shown
2 of 3
1. INTRODUCTION
1.1 Study deliveratives
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and forecast period years
1.6 General Study Assumptions
2. RESEARCH METHODOLOGY
2.1 Introduction
2.2 Analysis Methodology
2.3 Study timeline
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Model
2.4.4 Expert Validation
3. EXECUTIVE SUMMARY
4. KEY INFERENCES
5. MARKET OVERVIEW AND INDUSTRY TRENDS
5.1 Current market scenario
5.2 Porters Five Force Analysis
5.2.1 Bargaining Power of suppliers
5.2.2 Bargaining power of buyers
5.2.3 Degree of competition
5.2.4 Threat of substitution
5.2.5 Threat of new entrants
6. DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES ANALYSIS (DROC)
6.1 Market Drivers
6.1.1 Huge investment by Life science companies for R&D
6.1.2 Development of automated large-scale cell culture systems
6.1.3 Rise in Research and Development Investments
6.1.4 Rising need for organ transplantation
6.1.5 Use of 3D Cell Culture models as an alternative tool for invivo testing
6.1.6 Increasing focus on regenerative medicine
6.2 Market Restraints
6.2.1 Lack of experienced and skilled professionals
6.2.2 Budget restriction for small and medium sized laboratories
6.2.3 Lack of consistency in 3D cell culture products
6.2.4 Stringent process controls for advanced handling capabilities
6.3 Market opportunities
6.3.1 Use of microfluidic technology
6.4 Key Challenges
6.4.1 Ethical concern over use of animal sources
7. GLOBAL Defibrillators MARKET -SEGMENTATION
7.1 BY TECHNOLOGY
7.1.1 Extracellular matrices (Scaffolds)
7.1.2 Bioreactors
7.1.3 Gels
7.1.4 Scaffold-free platforms
7.1.5 Microchips
7.1.6 Others
7.2 BY APPLICATION
7.2.1 Research
7.2.2 Drug discovery
7.2.3 Tissue engineering
7.2.4 Clinical applications
7.2.5 Stem cell biology
7.2.6 Others
7.3 BY END USER
7.3.1 Research laboratories and institutes
7.3.2 Biotechnology and pharmaceutical industries
7.3.3 Hospitals and diagnostic centers
7.3.4 Others
8. Global Defibrillators market by Geography - Regional shares and forecast
8.1 North America
8.1.1 United States
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 UK
8.2.3 France
8.2.4 Italy
8.2.5 Spain & Portugal
8.2.6 Scandinavia
8.2.7 Benelux
8.2.8 Rest of Europe
8.3 Asia-Pacific
8.3.1 China
8.3.2 Japan
8.3.3 India
8.3.4 Australia & New Zealand
8.3.5 South Korea
8.3.6 Rest of Asia-Pacific
8.4 Middle East and Africa
8.4.1 GCC
8.4.2 South Africa
8.4.3 Rest of Middle East and Africa
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Rest of Latin America
9. Competitive Landscape
9.1 Merger and Acquisition Analysis
9.2 New Product Launches
9.3 Agreements, Collaborations & Partnerships
10. Company Profiles
10.1 3D Biomatrix
10.2 Inc (U.S.)
10.3 3D Biotek LLC (U.S.)
10.4 Becton
10.5 Dickinson and Company (U.S.)
10.6 Corning Incorporated (U.S.)
10.7 Thermo Fisher Scientific (U.S.)
10.8 Global Cell Solutions Inc
10.9 (U.S.)
10.10 InSphero AG (Switzerland)
10.11 Lonza Group (Switzerland)
10.12 Nano 3D Biosciences (U.S.)
10.13 Nanofiber Solutions Incorporation (U.S.)
10.14 Sigma Aldrich Corporation (U.S.)
10.15 Reinnervate Ltd (A subsidiary of ReproCELL) (U.K.).
11. Analyst Outlook for Investment Opportunities
12. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll